Browsing Tag
Australia
724 posts
AI productivity revolution looms: Only 2% of companies ready for huge gains, Infosys warns!
Companies worldwide recognize artificial intelligence (AI) as a transformative force, poised to significantly boost productivity and revolutionize industries.…
November 1, 2024
SKF completes strategic acquisition of John Sample Group’s lubrication division
SKF has successfully completed the acquisition of John Sample Group’s (JSG) Lubrication and Flow Management businesses, a move…
October 31, 2024
Arthur J. Gallagher & Co. expands reach with acquisitions of Filos Agency, Via Financial Group, and Redington Ltd
Arthur J. Gallagher & Co. has solidified its position in the insurance and financial services markets by announcing…
October 29, 2024
HCL Technologies bags major NSW government contract to modernize Sydney’s transport
HCL Technologies has solidified a powerful alliance with Transport for New South Wales (NSW) through a transformative five-year…
October 28, 2024
Arthur J. Gallagher expands with strategic acquisitions in Australia and UK
In a bid to strengthen its financial advisory footprint, Arthur J. Gallagher & Co. announced two key acquisitions,…
October 27, 2024
South32 sees aluminium production surge to 298,000 tonnes, up 5%
South32 has reported a 5% increase in its aluminium production for the first quarter of the financial year,…
October 21, 2024
Dubber Corporation launches A$25m equity raising to secure growth ambitions
In a significant financial move, Dubber Corporation Limited has announced a A$25 million equity raising, fully underwritten to…
October 11, 2024
Rio Tinto to become world’s third-largest lithium producer with Arcadium Lithium acquisition
Rio Tinto, one of the world’s foremost mining conglomerates, has announced its plan to acquire US-based Arcadium Lithium…
October 10, 2024
Orthocell secures key regulatory approval for Remplir in Singapore, paving way for ASEAN expansion
Orthocell, an Australian regenerative medicine company, has achieved a significant milestone with the receipt of major international regulatory…
October 8, 2024
Neuren Pharmaceuticals advances NNZ-2591 for Phelan-McDermid syndrome to Phase 3 clinical trial
Neuren Pharmaceuticals has secured approval from the United States Food and Drug Administration (FDA) to progress into the…
October 7, 2024